These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 29588372)

  • 1. Prognostic value of Ki67 analysed by cytology or histology in primary breast cancer.
    Robertson S; Stålhammar G; Darai-Ramqvist E; Rantalainen M; Tobin NP; Bergh J; Hartman J
    J Clin Pathol; 2018 Sep; 71(9):787-794. PubMed ID: 29588372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score.
    Robertson S; Acs B; Lippert M; Hartman J
    Breast Cancer Res Treat; 2020 Aug; 183(1):161-175. PubMed ID: 32572716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens.
    Tendl-Schulz KA; Rössler F; Wimmer P; Heber UM; Mittlböck M; Kozakowski N; Pinker K; Bartsch R; Dubsky P; Fitzal F; Filipits M; Eckel FC; Langthaler EM; Steger G; Gnant M; Singer CF; Helbich TH; Bago-Horvath Z
    Virchows Arch; 2020 Oct; 477(4):545-555. PubMed ID: 32383007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.
    Abubakar M; Orr N; Daley F; Coulson P; Ali HR; Blows F; Benitez J; Milne R; Brenner H; Stegmaier C; Mannermaa A; Chang-Claude J; Rudolph A; Sinn P; Couch FJ; Devilee P; Tollenaar RA; Seynaeve C; Figueroa J; Sherman ME; Lissowska J; Hewitt S; Eccles D; Hooning MJ; Hollestelle A; Martens JW; van Deurzen CH; ; Bolla MK; Wang Q; Jones M; Schoemaker M; Wesseling J; van Leeuwen FE; Van 't Veer L; Easton D; Swerdlow AJ; Dowsett M; Pharoah PD; Schmidt MK; Garcia-Closas M
    Breast Cancer Res; 2016 Oct; 18(1):104. PubMed ID: 27756439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts.
    Lundberg A; Lindström LS; Harrell JC; Falato C; Carlson JW; Wright PK; Foukakis T; Perou CM; Czene K; Bergh J; Tobin NP
    Clin Cancer Res; 2017 Dec; 23(24):7512-7520. PubMed ID: 28972043
    [No Abstract]   [Full Text] [Related]  

  • 6. The importance of tissue handling of surgically removed breast cancer for an accurate assessment of the Ki-67 index.
    Arima N; Nishimura R; Osako T; Nishiyama Y; Fujisue M; Okumura Y; Nakano M; Tashima R; Toyozumi Y
    J Clin Pathol; 2016 Mar; 69(3):255-9. PubMed ID: 26420767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer.
    Serna G; Simonetti S; Fasani R; Pagliuca F; Guardia X; Gallego P; Jimenez J; Peg V; Saura C; Eppenberger-Castori S; Ramon Y Cajal S; Terracciano L; Nuciforo P
    Breast; 2020 Oct; 53():102-110. PubMed ID: 32707454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer.
    Rewcastle E; Skaland I; Gudlaugsson E; Fykse SK; Baak JPA; Janssen EAM
    Breast Cancer Res Treat; 2024 Aug; 207(1):1-12. PubMed ID: 38797793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic ability of real-time quantitative polymerase chain reaction versus immunohistochemistry for Ki-67 assessment in breast cancer: An Indian perspective.
    Mehta A; Kumar D; Chadha P; Goswami M; Vishwakarma G; Panigrahi M; Suryavanshi M; Panaych A
    Indian J Med Res; 2019 Sep; 150(3):254-260. PubMed ID: 31719296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial intelligence algorithm accurately assesses oestrogen receptor immunohistochemistry in metastatic breast cancer cytology specimens: A pilot study.
    Li BC; Hammond S; Parwani AV; Shen R
    Cytopathology; 2024 Jul; 35(4):464-472. PubMed ID: 38519745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group.
    Nielsen TO; Leung SCY; Rimm DL; Dodson A; Acs B; Badve S; Denkert C; Ellis MJ; Fineberg S; Flowers M; Kreipe HH; Laenkholm AV; Pan H; Penault-Llorca FM; Polley MY; Salgado R; Smith IE; Sugie T; Bartlett JMS; McShane LM; Dowsett M; Hayes DF
    J Natl Cancer Inst; 2021 Jul; 113(7):808-819. PubMed ID: 33369635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer.
    Fasching PA; Gass P; Häberle L; Volz B; Hein A; Hack CC; Lux MP; Jud SM; Hartmann A; Beckmann MW; Slamon DJ; Erber R
    Breast Cancer Res Treat; 2019 Jun; 175(3):617-625. PubMed ID: 30868391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer.
    Dix-Peek T; Phakathi BP; van den Berg EJ; Dickens C; Augustine TN; Cubasch H; Neugut AI; Jacobson JS; Joffe M; Ruff P; Duarte RAB
    Breast Cancer Res Treat; 2023 May; 199(1):1-12. PubMed ID: 36867282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overrepresentation of human epidermal growth factor receptor 2 positive- and Luminal B breast cancer metastases in the eyes and orbit.
    Stålhammar G; Grossniklaus HE
    Eye (Lond); 2023 Aug; 37(12):2499-2504. PubMed ID: 36517577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics and Survival Outcomes of Infiltrating Lobular Carcinoma: A Retrospective Study of 365 Cases in China.
    Han B; Gu Z; Liu Z; Ling H
    Cancer Manag Res; 2022; 14():647-658. PubMed ID: 35210861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEAK1 promotes invasion and metastasis and confers drug resistance in breast cancer.
    Wang X; Zheng Y; Wang Y
    Clin Exp Med; 2022 Aug; 22(3):393-402. PubMed ID: 34554318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients.
    Egeland NG; Jonsdottir K; Lauridsen KL; Skaland I; Hjorth CF; Gudlaugsson EG; Hamilton-Dutoit S; Lash TL; Cronin-Fenton D; Janssen EAM
    Clin Epidemiol; 2020; 12():771-781. PubMed ID: 32801916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC).
    Zhao Y; Zheng R; Chen J; Ning D
    Cancer Cell Int; 2020; 20():289. PubMed ID: 32655321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear expression of BAP-1 in transvitreal incisional biopsies and subsequent enucleation of eyes with posterior choroidal melanoma.
    Herrspiegel C; Kvanta A; Lardner E; Ramsköld Cabaca L; Wells J; Bartuma K; Seregard S; Stålhammar G
    Br J Ophthalmol; 2021 Apr; 105(4):582-586. PubMed ID: 32522791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
    Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
    J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.